CoChat

The role of LSM1 in breast cancer: Shaping metabolism and tumor-associated macrophage infiltration

Tzeng, Yen-Dun Tony, Hsiao, Jui-Hu, Chu, Pei-Yi, Tseng, Ling-Ming, Hou, Ming-Feng, Tsang, Yi-Ling, Shao, Ai-Ning, Sheu, Jim Jinn-Chyuan, Li, Chia-Jung · 2023 · Pharmacological Research
Cited by 17

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.phrs.2023.107008

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 57

  1. Li, 2019, The molecular mechanism of epithelial-mesenchymal transition for breast carcinogenesis, Biomolecules, 9, 10.3390/biom9090476 · DOI
  2. Chu, 2022, Downregulation of ATP binding cassette subfamily a member 10 acts as a prognostic factor associated with immune infiltration in breast cancer, Aging (Albany NY), 14, 2252, 10.18632/aging.203933 · DOI
  3. Lin, 2023, Multi-omics and experimental analysis unveil theragnostic value and immunological roles of inner membrane mitochondrial protein (IMMT) in breast cancer, J. Transl. Med, 21, 10.1186/s12967-023-04035-4 · DOI
  4. Tarchi, 2023, Breast stiffness, a risk factor for cancer and the role of radiology for diagnosis, J. Transl. Med, 21, 10.1186/s12967-023-04457-0 · DOI
  5. Li, 2021, PD‑L1/PD‑1 blockade in breast cancer: the immunotherapy era, Oncol. Rep., 45, 5, 10.3892/or.2020.7831 · DOI
  6. Wilusz, 2013, Lsm proteins and Hfq: Life at the 3' end, RNA Biol., 10, 592, 10.4161/rna.23695 · DOI
  7. Montemayor, 2020, Molecular basis for the distinct cellular functions of the Lsm1-7 and Lsm2-8 complexes, RNA, 26, 1400, 10.1261/rna.075879.120 · DOI · Paper page
  8. Little, 2016, The CaSm (LSm1) oncogene promotes transformation, chemoresistance and metastasis of pancreatic cancer cells, Oncogenesis, 5, 10.1038/oncsis.2015.45 · DOI · Paper page
  9. Bouveret, 2000, A Sm-like protein complex that participates in mRNA degradation, EMBO J., 19, 1661, 10.1093/emboj/19.7.1661 · DOI · Paper page
  10. Sheth, 2003, Decapping and decay of messenger RNA occur in cytoplasmic processing bodies, Science, 300, 805, 10.1126/science.1082320 · DOI · Paper page
  11. Streicher, 2007, Transforming function of the LSM1 oncogene in human breast cancers with the 8p11-12 amplicon, Oncogene, 26, 2104, 10.1038/sj.onc.1210002 · DOI
  12. Noblejas-Lopez, 2021, Genomic mapping of splicing-related genes identify amplifications in LSM1, CLNS1A, and ILF2 in luminal breast cancer, Cancers, 13, 10.3390/cancers13164118 · DOI
  13. Ta, 2021, Potential therapeutic and prognostic values of LSM family genes in breast cancer, Cancers, 13, 10.3390/cancers13194902 · DOI
  14. Tzeng, 2022, Integrated analysis of pivotal biomarker of LSM1, immune cell infiltration and therapeutic drugs in breast cancer, J. Cell Mol. Med, 26, 4007, 10.1111/jcmm.17436 · DOI
  15. Watson, 2008, CaSm (LSm-1) overexpression in lung cancer and mesothelioma is required for transformed phenotypes, Am. J. Respir. Cell Mol. Biol., 38, 671, 10.1165/rcmb.2007-0205OC · DOI
  16. Peng, 2023, Interactions between MFAP5 + fibroblasts and tumor-infiltrating myeloid cells shape the malignant microenvironment of colorectal cancer, J. Transl. Med, 21, 10.1186/s12967-023-04281-6 · DOI
  17. Peng, 2022, Spatial transcriptomics atlas reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment components in colorectal cancer, J. Transl. Med, 20, 10.1186/s12967-022-03510-8 · DOI · Paper page
  18. Wang, 2022, Metabolism and polarization regulation of macrophages in the tumor microenvironment, Cancer Lett., 543, 10.1016/j.canlet.2022.215766 · DOI
  19. de Goede, 2020, Metabolic cancer-macrophage crosstalk in the tumor microenvironment, Biol. (Basel), 9
  20. Sciacovelli, 2016, Oncometabolites: unconventional triggers of oncogenic signalling cascades, Free Radic. Biol. Med, 100, 175, 10.1016/j.freeradbiomed.2016.04.025 · DOI · Paper page
  21. Martinez, 2008, Macrophage activation and polarization, Front Biosci., 13, 453, 10.2741/2692 · DOI · Paper page
  22. Martinez, 2009, Alternative activation of macrophages: an immunologic functional perspective, Annu Rev. Immunol., 27, 451, 10.1146/annurev.immunol.021908.132532 · DOI · Paper page
  23. Li, 2023, Metabolism, metabolites, and macrophages in cancer, J. Hematol. Oncol., 16, 10.1186/s13045-023-01478-6 · DOI · Paper page
  24. Bernard-Pierrot, 2008, Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer, Cancer Res, 68, 7165, 10.1158/0008-5472.CAN-08-1360 · DOI
  25. Yang, 2010, Transforming properties of 8p11-12 amplified genes in human breast cancer, Cancer Res, 70, 8487, 10.1158/0008-5472.CAN-10-1013 · DOI
  26. Li, 2021, Acetyl coenzyme a synthase 2 Acts as a prognostic biomarker associated with immune infiltration in cervical squamous cell carcinoma, Cancers, 13, 10.3390/cancers13133125 · DOI
  27. Bartha, 2021, TNMplot.com: a web tool for the comparison of gene expression in normal, tumor and metastatic tissues, Int J. Mol. Sci., 22, 10.3390/ijms22052622 · DOI · Paper page
  28. Chandrashekar, 2017, UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses, Neoplasia, 19, 649, 10.1016/j.neo.2017.05.002 · DOI · Paper page
  29. Li, 2021, Identification of novel biomarkers and candidate drug in ovarian cancer, J. Pers. Med, 11, 10.3390/jpm11040316 · DOI
  30. Chu, 2021, Multi-omics reveals the immunological role and prognostic potential of mitochondrial ubiquitin ligase MARCH5 in human breast cancer, Biomedicines, 9, 10.3390/biomedicines9101329 · DOI
  31. Gyorffy, 2021, Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer, Comput. Struct. Biotechnol. J., 19, 4101, 10.1016/j.csbj.2021.07.014 · DOI · Paper page
  32. Liao, 2022, Mitochondrial AAA protease gene associated with immune infiltration is a prognostic biomarker in human ovarian cancer, Pathol. Res Pr., 240
  33. Li, 2022, Prognostic significance of ferroptosis pathway gene signature and correlation with macrophage infiltration in cervical squamous cell carcinoma, Int Immunopharmacol., 112, 10.1016/j.intimp.2022.109273 · DOI
  34. Li, 2021, Dehydroepiandrosterone shifts energy metabolism to increase mitochondrial biogenesis in female fertility with advancing age, Nutrients, 13, 10.3390/nu13072449 · DOI
  35. Li, 2015, Synergistic protection of N-acetylcysteine and ascorbic acid 2-phosphate on human mesenchymal stem cells against mitoptosis, necroptosis and apoptosis, Sci. Rep., 5
  36. Liao, 2017, Development of a postcolumn infused-internal standard liquid chromatography mass spectrometry method for quantitative metabolomics studies, J. Proteome Res, 16, 1097, 10.1021/acs.jproteome.6b01011 · DOI
  37. Tsai, 2022, Expression status and prognostic significance of mitochondrial dynamics OPA3 in human ovarian cancer, Aging (Albany NY), 14, 3874, 10.18632/aging.204050 · DOI
  38. Galluzzi, 2018, Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018, Cell Death Differ., 25, 486, 10.1038/s41418-017-0012-4 · DOI · Paper page
  39. Chiu, 2021, Molecular machinery and pathophysiology of mitochondrial dynamics, Front Cell Dev. Biol., 9, 10.3389/fcell.2021.743892 · DOI
  40. Gomes, 2011, During autophagy mitochondria elongate, are spared from degradation and sustain cell viability, Nat. Cell Biol., 13, 589, 10.1038/ncb2220 · DOI · Paper page
  41. Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin., 68, 394
  42. Wang, 2020, The metabolic mechanisms of breast cancer metastasis, Front Oncol., 10
  43. Schwartzenberg-Bar-Yoseph, 2004, The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression, Cancer Res, 64, 2627, 10.1158/0008-5472.CAN-03-0846 · DOI · Paper page
  44. Jiang, 2011, p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase, Nat. Cell Biol., 13, 310, 10.1038/ncb2172 · DOI · Paper page
  45. Fruman, 2014, PI3K and cancer: lessons, challenges and opportunities, Nat. Rev. Drug Discov., 13, 140, 10.1038/nrd4204 · DOI · Paper page
  46. Araki, 2018, Mechanism of resistance to endocrine therapy in breast cancer: the important role of PI3K/Akt/mTOR in estrogen receptor-positive, HER2-negative breast cancer, Breast Cancer, 25, 392, 10.1007/s12282-017-0812-x · DOI · Paper page
  47. McCarthy, 2020, Different associations of tumor PIK3CA mutations and clinical outcomes according to aspirin use among women with metastatic hormone receptor positive breast cancer, BMC Cancer, 20, 10.1186/s12885-020-06810-8 · DOI
  48. Ning, 2023, NUCB2/Nesfatin-1 drives breast cancer metastasis through the up-regulation of cholesterol synthesis via the mTORC1 pathway, J. Transl. Med, 21
  49. Pavlova, 2016, The emerging hallmarks of cancer metabolism, Cell Metab., 23, 27, 10.1016/j.cmet.2015.12.006 · DOI · Paper page
  50. Chen, 2021, Prognostic value and potential molecular mechanism of the like-Sm gene family in early-stage pancreatic ductal adenocarcinoma, Transl. Cancer Res, 10, 1744, 10.21037/tcr-20-3056 · DOI
  51. Qian, 2010, Macrophage diversity enhances tumor progression and metastasis, Cell, 141, 39, 10.1016/j.cell.2010.03.014 · DOI · Paper page
  52. Qiu, 2018, Tumor-associated macrophages in breast cancer: Innocent bystander or important player?, Cancer Treat. Rev., 70, 178, 10.1016/j.ctrv.2018.08.010 · DOI · Paper page
  53. Murdoch, 2005, Macrophage migration and gene expression in response to tumor hypoxia, Int J. Cancer, 117, 701, 10.1002/ijc.21422 · DOI · Paper page
  54. Casazza, 2013, Impeding macrophage entry into hypoxic tumor areas by Sema3A/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity, Cancer Cell, 24, 695, 10.1016/j.ccr.2013.11.007 · DOI · Paper page
  55. Henze, 2016, The impact of hypoxia on tumor-associated macrophages, J. Clin. Invest, 126, 3672, 10.1172/JCI84427 · DOI · Paper page
  56. Colegio, 2014, Functional polarization of tumour-associated macrophages by tumour-derived lactic acid, Nature, 513, 559, 10.1038/nature13490 · DOI · Paper page
  57. Cai, 2023, Correlation between LSM1 expression and clinical outcomes in glioblastoma and functional mechanisms, Int J. Genom., 2023

Cited by

See all 17

Metadata

Authors
Tzeng, Y.-D. T., Hsiao, J.-H., Chu, P.-Y., Tseng, L.-M., Hou, M.-F., Tsang, Y.-L., Shao, A.-N., Sheu, J. J.-C., & Li, C.-J.
Venue
Pharmacological Research
Publisher
Elsevier BV
Published
2023-12
Volume
198
Pages
107008
ISSN
1043-6618
Cited by
17
References
1
Language
en
Licence
Funders
  • National Science and Technology Council
  • Ministry of Science and Technology, Taiwan (111-2314-B-075B-004-MY3, 111-2314-B-075B-017, NSTC 112-2314-B-075B-008)
  • Yen Tjing Ling Medical Foundation
  • Kaohsiung Veterans General Hospital

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.